This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Irina Abecassis: Innovator in Cancer Treatment
Introduction
Irina Abecassis is a prominent inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on enhancing the effectiveness of chemotherapy by utilizing PARP inhibitors.
Latest Patents
Irina Abecassis holds a patent titled "PARP genomic variants conferring resistance and sensitization to chemotherapy under inhibition." This patent describes a method for selecting cancer patients who may benefit from treatment with a PARP1 inhibitor, such as verliparib (ABT-888), in conjunction with traditional chemotherapeutic agents. The method involves detecting mutations in a non-coding region of the PARP1 gene, which can indicate the suitability of the treatment.
Career Highlights
Abecassis is affiliated with the University of Pittsburgh, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential to improve cancer treatment outcomes and personalize therapy for patients.
Collaborations
Irina collaborates with notable colleagues, including Panagiotis Benos and Marjorie Romkes. These partnerships enhance her research efforts and contribute to the advancement of cancer treatment methodologies.
Conclusion
Irina Abecassis is a trailblazer in the realm of cancer research, with her innovative patent paving the way for more effective treatment options. Her contributions to the field are invaluable and hold promise for future advancements in cancer therapy.